Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Lyme Disease Antibodies Attached to Nanotubes

By LabMedica International staff writers
Posted on 10 Apr 2013
A fast and accurate sensor for a Lyme disease antigen has been developed that may pave the way for a diagnostic device. More...


The potential of antibody-functionalized single-walled carbon nanotube (SWNT) field-effect transistors (FETs) has been examined which may lead to diagnostics that can detect the organism itself.

Scientists at the University of Pennsylvania (Philadelphia, PA, USA) fabricated the device and attached monoclonal Lyme antibodies specific for the Borrelia burgdorferi p41 flagellar antigen (antibodies-online Inc.; Atlanta, GA, USA) and histidine tagged Lyme antigen containing the p41 flagellar immunodominant region which is also known as flagellin (ProSpec; East Brunswick, NJ, USA). Attachment of B. burgdorferi (Lyme) flagellar antibodies to the nanotubes was verified by atomic force microscopy and electronic measurements.

After using atomic-force microscopy to show that antibodies had indeed bound to the exteriors of their nanotube transistors, the investigators tested them electrically to get a baseline reading. They then put the nanotubes in solutions that contained different concentrations of the target Lyme bacteria protein. The smallest concentration the nanotube devices could detect was four ng/mL of protein of solution.

Early diagnosis is critical in treating Lyme disease, nevertheless, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection. Misdiagnosed patients may go untreated and thus progress to late-stage Lyme disease, where they face longer and more invasive treatments, as well as persistent symptoms.

A.T. Charlie Johnson, PhD, a professor of physics and senior author of the study said, "If we were to do this type of test on a person's blood now, however, we would say the person has the disease. The first thought is that if you detect any protein coming from the Lyme organism in your blood, you are infected and should get treatment right away." The study was published online on February 4, 2013, in the journal Biosensors and Bioelectronics.

Related Links:
University of Pennsylvania
antibodies-online Inc.
ProSpec



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.